Zhejiang Int'l Group Co.,Ltd.
000411.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.74B
Close$
$22.84
133.7% upside
Current Fair Value
133.7% upsideUndervalued by 133.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.74 Billion |
|---|---|
| Enterprise Value | $9.98 Billion |
| Dividend Yield | $0.35 (3.48%) |
| Earnings per Share | $0.96 |
| Beta | 0.25 |
| Outstanding Shares | 558,484,106 |
Return
| Return on Equity | 8.12% |
|---|---|
| Return on Assets | 2.56% |
| Return on Invested Capital | 13.43% |
Valuation & Multiples
| P/E Ratio | 12.24 |
|---|---|
| PEG | -55.35 |
| Price to Sales | 0.16 |
| Price to Book Ratio | 0.89 |
| Enterprise Value to Revenue | 0.29 |
| Enterprise Value to EBIT | 11.16 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.62 |
| Debt to Equity | 1.12 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang Int'l Group Co.,Ltd.
3,603 employees
CEO: Yang Wang Founded in 1950, Zhejiang Int'l Group Co.,Ltd. is an enterprise based in Hangzhou, China, specializing in both the bulk distribution and direct sale of pharmaceutical products and medical instruments.